Share Name Share Symbol Market Type Share ISIN Share Description
Akers Biosciences, Inc LSE:AKR London Ordinary Share US00973E1029 COM SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 127.50p 120.00p 135.00p 127.50p 127.50p 127.50p 404.00 07:32:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1.4 -6.5 -122.8 - 9.23

Akers Biosciences Share Discussion Threads

Showing 3751 to 3768 of 3775 messages
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older
DateSubjectAuthorDiscuss
17/1/2017
08:24
Must be still collecting the issue money; Does not feel right
norbus
16/1/2017
12:03
Lots of words, vaguely pertaining to the (endlessly repeated) point that you don't like Dr Akers.Beyond that, as a previous poster suggested, nothing of much use.
wigwammer
16/1/2017
11:06
Nobody throws good money after bad unless they were great stock pickers like Neil Woodford who is looking to recruit; With a closing date last Thursday, I suppose they are cutting the application due to massive over subscription and attention to the-inauguration balls invitations on offer to The Akers
norbus
16/1/2017
10:38
"a constructive comment" (or at least something pertaining to knowledge of the company)Qaz - It was interesting to note in the last conference call that the breakeven level of sales had fallen from circa $7m to $4.6m pa, which implies cash burn has dropped from circa $80k pw to closer to $35k. This implies the newly raised cash may give them a 12-18 month window. Over that time it is possible they get traction on the wellness side - the market would, I suspect, richly reward even marginal success on this front, given a market cap of sub $10m.I'm disappointed management did not participate in the cash raise. It doesn't make a great deal of sense - even a token level of participation would have had an amplified impact on confidence. Perhaps they were limited for some reason or perhaps they intend purchasing in the after market. I think breath actuated tests are still a great idea - particularly when targeting a wellness market populated by health enthusiasts. With some medtechs the risk is getting the products to market - here, the risks are clearly related to trust. But nonetheless, if it works out from this valuation level and the risks are ameliorated, investors will be very well rewarded, imo dyor.
wigwammer
16/1/2017
10:23
Enjoy Transylvania.
wigwammer
14/1/2017
17:41
There is plenty of life in me; sadly you can't say the same about Walter's outfit. Just sucking money
norbus
13/1/2017
21:57
Cheer up Norbus,there's life in you yet.
algernon2
13/1/2017
13:41
Basket case
norbus
13/1/2017
10:02
"These could half again in a week". And you could make a constructive comment in a week. Strange things do sometimes happen.....
qazwsxedc69
12/1/2017
06:38
Not silk purse from a sow's ear ; today is the deadline to close. I hope for all holders sake that the $1.20 pricing is from greed and not despair. These could half again in a week
norbus
11/1/2017
15:22
Duck or no dinner.
norbus
10/1/2017
09:16
something not right whichever way you look at it. Someone stealing a chunk cheap, or curtains being measured
norbus
10/1/2017
09:01
The initial S3 form included the comment: "...and a per share price of $3.30 based on the closing sale price of our common stock on October 18, 2016". The price of $1.20 with warrants at $1.50 suggests to me either gross incompetence or, as you say Norbus, no confidence in the company and the management. Or perhaps both.
mcmather
10/1/2017
07:45
$1.2 for $2000000 ! I doubt this is careful housekeeping and most likely the market had enough; Even money they will not make it; I say that, because if revenues were on doorstep from China,they can underwrite them and at much higher than $1.20; I also think this money is coming from insider back pockets. I over rated the CEO on his past M&A record. I think he is past his sell by date
norbus
09/1/2017
07:42
mcm Looking for the RNS I could not find on their website, I see so many people around the company; board management etc.. You'd think they are running a big company
norbus
04/1/2017
07:08
And again I reckon they are seriously stuck for some real news before they put their hands out to siphon more money into the benefits pot. Critical Junction if China does not come through
norbus
03/1/2017
20:28
Likewise algernon. Still no new SEC filings for AKERs: hTtp://www.nasdaq.com/symbol/aker/sec-filings
mcmather
31/12/2016
19:08
Happy New year to all Akers Biosciences Holders: May 2017 be Merry and Bright for us all.
algernon2
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170117 21:12:59